Arcadia Biosciences logo
Arcadia Biosciences RKDA
$ 4.82 2.55%

Quarterly report 2024-Q3
added 11-12-2024

report update icon

Arcadia Biosciences Financial Ratios 2011-2024 | RKDA

Annual Financial Ratios Arcadia Biosciences

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.4 -0.3 -0.0 -5.9 -1.2 -1.0 -0.7 -2.3 -4.7 - - - -

P/S

1.1 0.6 0.1 3.4 29.9 9.3 2.8 13.9 15.6 - - - -

EPS

-10.6 -17.7 -27.6 -0.5 -4.5 -3.6 -7.3 -8.8 -0.7 -10.7 - - -

EV (Enterprise Value)

6.45 M -8.14 M -15.5 M 32.1 M 50.8 M 12.8 M 10.9 M 76.7 M 94.3 M 10.2 M 26.8 M 19 M -

EBITDA per Share

-11 -22.6 -65 -2.1 -3.06 -4.44 -6.51 -8.26 -10.7 - - - -

EV/EBITDA

0.5 -0.8 -1.4 -0.1 -0.2 -3.7 -5.6 - - - -

PEG

-0.0 -0.0 -0.0 -0.07 0.05 -0.02 -0.04 -0.06 0.15 - - - -

P/B

0.5 0.2 0.0 1.0 4.5 1.1 1.4 2.0 2.1 - - - -

P/CF

-0.4 -0.3 -0.0 -0.8 -1.9 -1.0 -0.8 -2.6 -5.5 - - - -

ROE %

-108.88 -73.10 -47.15 -16.79 -373.85 -105.19 -196.17 -88.40 -44.64 - - - -

ROA %

-70.95 -53.16 -33.38 -9.83 -88.43 -56.11 -94.79 -34.69 -24.19 - - - -

ROCE %

-108.54 -66.60 -114.26 -52.62 -75.86 -80.45 -109.74 -34.84 -21.98 - - - -

Current Ratio

2.8 3.6 3.5 5.0 5.0 7.5 4.3 16.7 15.1 - - - -

DSO

59.4 63.7 74.7 63.9 188.0 41.9 112.0 61.0 47.6 - - - -

DIO

236.6 202.0 172.8 267.6 739.9 99.9 295.4 102.8 120.3 - - - -

DPO

94.3 69.3 44.8 288.2 202.9 157.4 472.0 90.5 173.5 - - - -

Operating Cycle

296.1 265.8 247.5 331.5 927.9 141.8 407.3 163.8 167.9 - - - -

Cash Conversion Cycle

201.7 196.5 202.7 43.3 724.9 -15.5 -64.7 73.3 -5.6 - - - -

All numbers in USD currency

Quarterly Financial Ratios Arcadia Biosciences

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-1.18 0.78 -1.78 - -1.89 0.61 -10.86 - -4.67 -6.81 -8.09 - -0.1 -0.24 0.11 - -0.6 -1.04 0.29 - -2.04 0.84 -2.64 - 0.93 -2.02 -4.86 - -2.12 -1.88 -1.9 - -0.09 -0.1 -0.12 - -0.11 -0.19 -3.71 - -4.19 -3.08 -1.69 - - - - - - - - - - - -

EBITDA per Share

-1.29 1.47 -2.21 - -0.96 -1.05 -4.39 - -6.38 -6.59 -8.07 - -0.36 -0.33 -0.27 - -0.67 -0.72 -0.66 - -0.87 -0.97 -0.88 - -0.83 -1.35 -1.73 - -1.59 -1.68 -1.75 - -0.08 -0.09 -0.11 - -0.09 -0.14 -1.75 - -2.75 -2.34 -1.21 - - - - - - - - - - - -

ROE %

-46.09 -47.09 -51.51 -68.25 -79.71 -74.50 -93.25 -40.81 -46.22 -40.17 -38.76 -14.43 -37.49 -55.13 -77.37 -48.89 -233.02 -394.09 -304.16 -292.82 -398.17 -319.39 -479.57 -315.72 -511.89 -602.71 -693.69 -588.50 -607.31 -429.95 -254.28 -62.69 -74.17 -66.85 -55.49 -35.05 -13.42 19.70 50.48 47.37 47.37 25.74 4.10 - - - - - - - - - - - -

ROA %

-30.51 -30.87 -33.91 -38.73 -47.04 -44.42 -58.28 -30.99 -34.66 -30.02 -26.88 -8.96 -22.45 -32.28 -45.08 -28.63 -72.18 -102.24 -68.77 -69.26 -125.46 -138.10 -207.22 -168.41 -263.21 -301.80 -340.49 -284.38 -291.76 -204.34 -117.60 -24.60 -30.82 -29.66 -26.57 -18.99 -92.67 -160.14 -228.87 -161.33 -161.33 -87.65 -13.97 - - - - - - - - - - - -

ROCE %

- - - - -15.95 -31.90 -46.04 -45.37 -67.03 -72.74 -76.61 -51.32 -78.66 -84.34 -91.14 -73.03 -153.40 -206.44 -246.30 -199.78 -231.77 -183.37 -154.44 -97.67 -142.81 -155.98 -166.92 -141.31 -159.00 -131.55 -104.20 -59.24 -69.76 -62.60 -52.10 -24.89 -17.88 -0.34 14.38 15.95 15.95 8.94 3.05 - - - - - - - - - - - -

Current Ratio

3.0 3.0 2.9 2.8 2.9 3.0 2.2 3.6 3.6 4.2 4.5 3.5 3.1 2.5 2.8 2.5 2.5 2.5 2.5 1.3 1.3 1.3 1.3 2.1 2.1 2.1 2.1 1.9 1.9 1.9 1.9 1.6 1.6 1.6 1.6 2.2 2.2 2.2 2.2 0.9 0.9 0.9 - - - - - - - - - - - - -

DSO

51.1 55.9 46.0 - 32.8 54.6 79.4 - 191.2 78.3 58.6 - 49.9 73.4 138.8 - 408.6 456.6 296.5 - 140.1 270.6 221.5 - 40.7 34.5 297.6 - 190.7 113.3 70.8 - 29.6 44.2 56.5 - 35.3 45.0 97.9 - 63.3 72.9 34.5 - - - - - - - - - - - -

DIO

80.2 202.5 148.4 - 324.7 404.0 325.7 - 267.6 86.2 101.2 - 169.8 188.6 345.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - 18.6 - - - 38.7 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

131.3 258.4 257.1 - 357.5 458.6 405.1 - 458.9 164.5 159.8 - 219.7 262.0 483.9 - 408.6 456.6 296.5 - 140.1 270.6 221.5 - 40.7 34.5 297.6 - 190.7 113.3 70.8 - 29.6 44.2 56.5 - 35.3 45.0 97.9 - 63.3 72.9 34.5 - - - - - - - - - - - -

Cash Conversion Cycle

131.3 258.4 257.1 - 357.5 458.6 405.1 - 458.9 164.5 141.2 - 219.7 262.0 445.2 - 408.6 456.6 296.5 - 140.1 270.6 221.5 - 40.7 34.5 297.6 - 190.7 113.3 70.8 - 29.6 44.2 56.5 - 35.3 45.0 97.9 - 63.3 72.9 34.5 - - - - - - - - - - - -

All numbers in USD currency